WILMINGTON, Del.--(BUSINESS WIRE)-- FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by ...

The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration. The approval makes FluMist the only flu vaccine in ...

Given that cannabis use is increasing in the United States, pharmacological treatment options to treat cannabis use disorder are needed. Opioid antagonists modulate cannabinoid effects and may offer a ...

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory ...

Previously, the treatment had only been available as a lyophilized powder for reconstitution that required administration by a healthcare professional. The Food and Drug Administration has approved ...

Credit: Apellis The Empaveli Injector is expected to be available by the end of October. The Food and Drug Administration (FDA) has approved a single-use, disposable, on-body injector for ...

Please provide your email address to receive an email when new articles are posted on . FluMist is now approved for self- or caregiver-administration for people aged 2 to 49 years. The nasal spray is ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...